Pharmacist

PETER CHAD ADAMOVICH

***** * **** ** #****, Scottsdale, AZ 85254 859-***-**** *.*********@*****.*** EDUCATION

Mayo Clinic Arizona 2019 – Present

Post Graduate Year One Residency

University of Utah, College of Pharmacy 2015 – 2019 Pharm.D.

Brigham Young University 2011 – 2015

B.S. Biochemistry

PROFESSIONAL LICENSURE/CERTIFICATIONS

Arizona Pharmacy License (S024102) Expires Nov. 1, 2020 Clinician Educators Program, A Post-Graduate Teaching and Learning Curriculum Completed May 2020 Midwestern University College of Pharmacy-Glendale

• Attended 4 live seminars totaling 26 hours of contact time

• Completed 2 mentored teaching experiences including a grand rounds lecture

• Created Philosophy of Teaching Statement and Teaching Portfolio Advanced Cardiac Life Saving (ACLS) + Basic Life Saving (BLS) Certification Expires Aug. 18, 2021 APhA Pharmacy-Based Immunization Delivery Completed 2015 PROFESSIONAL EXPERIENCE

PGY1 Pharmacy Resident Jul. 2019 – Present

Mayo Clinic Hospital, 5777 E Mayo Blvd Phoenix, AZ 85054

• Responsible for patient assessment, treatment evaluation, ordering tests and labs, drug dosing, and dispensing

• Perform sterile/non-sterile compounding, inventory management, drug information and clinical staff advising

• Comply with regulatory and legal framework surrounding drug scheduling, and maintaining pharmacy security

• Rotations in many practice areas, including infectious disease, medicine, transplant, critical care and heme/onc

• Oral and written education provided to healthcare providers and patients

• Performed MUE, implementing changes to allow scheduling of additional 27-51 outpatient infusions yearly

• Proposed and carried out retrospective study of neutropenia prophylaxis in stem cell transplant patients

• Assessed and implemented USP 800 readiness changes prior to Mayo Clinic’s implementation Research Assistant / Formulation Consultant May 2018 – May 2019 Anticonvulsant Drug Development Program

University of Utah College of Pharmacy, 30 2000 E, Salt Lake City, UT 84112

• Designed feed pellet formulation for rodent drug delivery in animal studies

• Optimized formula to accommodate a variety of drugs, accounting for taste, stability, smell, and potency

• Developed system for in-house mass compounding of rodent feed pellets Poison Information Provider May 2015 – May 2019

Utah Poison Control Center

University of Utah College of Pharmacy, 30 2000 E #4540, Salt Lake City, UT 84112

• Managed and documented poison emergencies and medication errors for 30-40 patient-callers per week

• Quickly assessed the situation, triaged the patient, provided recommendations, and followed up

• Provided drug information, including PK/PD, toxicology, antidotes/reversal, and monitoring

• Performed quality improvement surveys to improve case management and patient satisfaction Research Assistant May 2016 – May 2018

Pharmaceutics Department

University of Utah College of Pharmacy, 30 2000 E, Salt Lake City, UT 84112

• Performed protein engineering and expression using bacterial and mammalian cell lines

• Performed DNA cloning and expression using bacterial vectors

• Protein analysis using FPLC, mass spectrometry, fluorometry, spectrophotometry, and immunoassays

• Investigated complementation assays using antibody-conjugation vs fusion protein expression PETER CHAD ADAMOVICH –LAST UPDATED JUNE 3, 2020 PAGE 2 PGY-1 RESIDENCY ROTATIONS AT MAYO CLINIC ARIZONA (4 WEEKS) Solid Organ Transplant (Kidney/Pancreas) May 2020 – Jun. 2020 Cassandra Votruba, Pharm.D.

• Managed 20-30 patients daily, rounding with kidney transplant service and kidney consult service

• Managed immunosuppression and prophylaxis, recommending adjustments to providers

• Documented notes in EHR, addressing immunosuppression, prophylaxis, and other management Bone Marrow Transplant Apr. 2020 – May 2020

Maggie McCallen, Pharm.D. BCOP

• Managed 15-20 hematology patients daily, focusing on auto/allo stem cell transplant, and CAR-T

• Provided topic lectures every other day to providers on Hematology services

• Managed immunosuppression, pain, chemo-induced toxicities, and infection control for patients Investigational Drug Services Mar. 2020 – Apr. 2020 Todd Luckritz, Pharm.D.

• Evaluated 1-4 industry/NIH research protocols daily for budgeting and study facilitation

• Studies included cancers, neurological diseases, Covid-19, and other chronic diseases

• Assessed appropriateness of investigational therapy prior to dispensing to patients

• Developed study drug reference forms for physician, nursing, and patient education Internal Medicine II Feb. 2020 – Mar. 2020

Harn Shiue, Pharm.D. MSc

• Rounded with medicine service, managing up to 36 patients daily, including acute and chronic illness

• Precepted 4th year pharmacy student during beginnings of Covid-19 pandemic

• Presented and facilitated weekly topic discussions, and provided education to medical residents Critical Care Jan. 2020 – Feb. 2020

Alicia Sacco, Pharm.D. BCCCP

• Managed drug dosing for patients using a variety of renal replacement modalities

• Presented journal club on SMART study to intensivists and members of ICU team

• Attended all code blue alerts while on-site at the hospital Surgery (2 Weeks) Dec. 2019 – Dec. 2019

Justin Mendoza, Pharm.D.

• Performed sterile compounding for six hours a day to support procedural areas

• Provided pharmacist training on THAM and Gliolan, including dosing and monitoring

• Evaluated MKO Melt for potential utilization at Mayo Clinic for pre-operative sedation Solid Organ Transplant (Heart) Nov. 2019 – Dec. 2019 Jenise Stephen, Pharm.D. BCPS

• Rounded on full heart failure / heart transplant service, roughly 20-25 patients daily

• Monitored and adjusted immunosuppression for 5-12 patients daily

• Monitored use of HCV therapies in select patients with HCV+ donors

• Monitored pharmacotherapy, appropriateness of antibiotics, and renal dosing Pharmacy Informatics (2 Weeks) Oct. 2019 – Nov. 2019 Vishal Shah, Pharm.D.

• Managed EPIC backend – created medication records and order sets

• Identified and fixed dispensing discrepancies in EPIC

• Worked with reporting systems to identify process improvements

• Applied analytics to improve ordering heuristics and automated dispensing prioritization Hematology/Oncology Sep. 2019 – Oct. 2019

Danielle Villa, Pharm.D.

• Performed SWOT analysis for Mayo’s early implementation of USP 800

• Rounded with palliative medicine and medical oncology teams, providing therapy recommendations

• Presented in-service on immune checkpoint inhibitor toxicity to medical oncology team PETER CHAD ADAMOVICH –LAST UPDATED JUNE 3, 2020 PAGE 3 Infectious Disease Aug. 2019 – Sep. 2019

Lynn Chan, Pharm.D.

• Rounded with infectious disease team, managing up to six patients daily

• Monitored vancomycin PK/PD and adjusted vancomycin regimens for these patients

• Performed 3-5 topic discussions per week on medications and disease states Internal Medicine I Jul. 2019 – Aug. 2019

Angela Feldman, Pharm.D. BCPS

• Rounded with internal medicine team, managing full service of 10-15 patients by end of week four

• Managed variety of acute and chronic illnesses, including diabetes, hypertension, pain and infections

• Developed and presented anticoagulation dosing guideline to internal medicine team RESEARCH EXPERIENCE

Clinical utility of non-fluoroquinolones for neutropenia prophylaxis in Nov. 2019 – Present patients with allogeneic stem cell transplant

Mayo Clinic Hospital, Arizona

Investigated clinical differences between fluoroquinolones and alternative antibiotics for neutropenia prophylaxis in allogeneic stem cell transplant patients, and whether fluoroquinolones offer any benefits compared to alternative antimicrobial prophylaxis

Medication use evaluation of eculizumab and ravulizumab-cwvz Aug. 2019 – Dec. 2019 Mayo Clinic Hospital, Arizona

Evaluated compliance with required meningococcal vaccination and prophylaxis, and created institutional guideline to assist prescribers with appropriately managing patients receiving complement inhibitors. Implemented enterprise change to allow 27-55 additional outpatient infusion patients yearly Development of a novel split-enzyme immunoassay for the clinical monitoring May. 2016 – May. 2019 of anti-TNF therapeutics

University of Utah College of Pharmacy, Dept of Pharmaceutics: Owen Lab Participated in the development and optimization of a one-step ternary complementation immunoassay for the rapid detection of anti-TNF inhibitors in human serum. Optimized assay conditions to maximize resolution, signal to noise ratio and limit of detection PROFESSIONAL INVOLVEMENT

College of Psychiatric and Neurologic Pharmacists Dec. 2015 – Apr. 2018

• Co-Founder/President, University of Utah Chapter American Pharmacists Association May 2016 – May 2017

• Vice President of Policy, University of Utah Chapter PEER REVIEWER

Journal of Intensive Care Medicine 2019

HONORS

Phi Lambda Sigma, University of Utah Chapter Oct. 2018 NATIONAL CONFERENCE PAPERS AND PRESENTATIONS

Medication Use Evaluation of Soliris and Ultomiris Dec. 11, 2019 Presented poster at ASHP Midyear in Las Vegas, NV regarding Mayo Clinic’s utilization of Soliris and Ultomiris, including vaccine compliance, and infusion time optimization LANGUAGES

English - Native Language

Spanish – Advanced speech, intermediate to advanced reading and writing

Contact this candidate